Triple negative breast cancer (TNBC) and non-small cell lung cancer (NSCLC) are amongst
the most aggressive forms of solid tumors. TNBC is highlighted by absence of genetic …

Simple Summary Despite the increased use of neoadjuvant chemotherapy in the early
setting of breast cancer, there is a clinical need for predictive markers of response in daily …

Dendritic cells (DCs) promote adaptive immunity by cross-presenting antigen-based
epitopes to CD8+ T cells. DCs process internalized protein antigens into peptides that enter …

Purpose Some studies have shown that Immune checkpoint inhibitors (ICIs) have a
favorable efficacy in advanced triple negative breast cancer (TNBC) patients, but the results …

Objective Triple-negative breast cancer (TNBC) is a subtype of breast cancer with a poor
prognosis that seriously threatens women's health. There is still a lack of effective …

Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of several
malignancies, improving patient survival and quality of life. Endocrinopathies have emerged …

Simple Summary Breast cancer emergencies have become a rapidly evolving field in
medicine during the last ten years. Carcinogenesis is a multiparametric process that …

Background The expression of immune checkpoint receptors (ICRs) on tumor-infiltrating
lymphocytes (TILs) is associated with better response to immunotherapies via immune …

Abstract Triple-Negative Breast Cancer is the most aggressive form and accounts the 15%−
25% of all breast cancer. Receptors are absent in triple-negative breast cancer, which …

Seroma development after breast cancer surgery is the most common postoperative
complication seen after mastectomy but neither its origin nor its cellular composition is …